StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$75.58−0.52 (-0.68%)

Close on Nov 18, 2026Market cap $1.73BP/E 26.5Yield 1.06%

LeMaitre Vascular revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

LeMaitre Vascular's revenue for the twelve months ending Jun 30, 2026 was $262.43M, up 11.8% year over year. For fiscal 2025 it was $249.60M, up 13.5% from the year before. Over ten years it grew 12.3% a year on average. The highest annual figure on record is $249.60M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$249.60M+13.5%
FY2024Dec 31, 2024$219.86M+13.6%
FY2023Dec 31, 2023$193.48M+19.7%
FY2022Dec 31, 2022$161.65M+4.7%
FY2021Dec 31, 2021$154.42M+19.4%
FY2020Dec 31, 2020$129.37M+10.4%
FY2019Dec 31, 2019$117.23M+11.0%
FY2018Dec 31, 2018$105.57M+4.7%
FY2017Dec 31, 2017$100.87M+13.1%
FY2016Dec 31, 2016$89.15M+13.8%
FY2015Dec 31, 2015$78.35M+10.2%
FY2014Dec 31, 2014$71.10M+10.1%
FY2013Dec 31, 2013$64.55M+13.8%
FY2012Dec 31, 2012$56.74M-1.6%
FY2011Dec 31, 2011$57.69M+2.9%
FY2010Dec 31, 2010$56.06M+10.1%
FY2009Dec 31, 2009$50.91M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$70.38M+9.6%
Q1 FY2026Mar 31, 2026$66.55M+11.2%
Q4 FY2025Dec 31, 2025$64.45M+15.7%
Q3 FY2025Sep 30, 2025$61.05M+11.4%
Q2 FY2025Jun 30, 2025$64.23M+15.0%
Q1 FY2025Mar 31, 2025$59.87M+12.0%
Q4 FY2024Dec 31, 2024$55.72M+14.0%
Q3 FY2024Sep 30, 2024$54.82M+15.6%
Q2 FY2024Jun 30, 2024$55.85M+11.4%
Q1 FY2024Mar 31, 2024$53.48M+13.6%
Q4 FY2023Dec 31, 2023$48.88M+19.4%
Q3 FY2023Sep 30, 2023$47.41M+21.5%
Q2 FY2023Jun 30, 2023$50.12M+19.0%
Q1 FY2023Mar 31, 2023$47.08M+19.0%
Q4 FY2022Dec 31, 2022$40.95M+3.7%
Q3 FY2022Sep 30, 2022$39.03M+1.7%
Q2 FY2022Jun 30, 2022$42.11M+3.5%
Q1 FY2022Mar 31, 2022$39.56M+10.2%
Q4 FY2021Dec 31, 2021$39.50M+5.2%
Q3 FY2021Sep 30, 2021$38.37M+5.4%
Q2 FY2021Jun 30, 2021$40.67M+63.7%
Q1 FY2021Mar 31, 2021$35.88M+17.5%
Q4 FY2020Dec 31, 2020$37.55M+24.5%
Q3 FY2020Sep 30, 2020$36.42M+25.1%
Q2 FY2020Jun 30, 2020$24.85M-15.7%
Q1 FY2020Mar 31, 2020$30.55M+7.3%
Q4 FY2019Dec 31, 2019$30.17M+6.3%
Q3 FY2019Sep 30, 2019$29.10M+20.4%
Q2 FY2019Jun 30, 2019$29.48M+9.1%
Q1 FY2019Mar 31, 2019$28.48M+9.6%
Q4 FY2018Dec 31, 2018$28.39M+8.5%
Q3 FY2018Sep 30, 2018$24.17M-2.6%
Q2 FY2018Jun 30, 2018$27.02M+4.9%
Q1 FY2018Mar 31, 2018$25.99M+7.7%
Q4 FY2017Dec 31, 2017$26.15M+12.3%
Q3 FY2017Sep 30, 2017$24.82M+6.9%
Q2 FY2017Jun 30, 2017$25.75M–
Q1 FY2017Mar 31, 2017$24.14M–
Q4 FY2016Dec 31, 2016$23.29M–
Q3 FY2016Sep 30, 2016$23.22M–

More LeMaitre Vascular figures

See a number that looks wrong?